Connect with us

Health

Can the EU resist US pressure on medicine prices?

SHARE:

Published

1 week ago

on

We use your sign-up to provide content in ways you've consented to and to improve our understanding of you. You can unsubscribe at any time.

Europe should resist US pressure to pay more for medicines and present a united front rather than allowing Washington to negotiate on a country-by-country basis, speakers said during a debate organised by the EU consumer organization BEUC.

The discussion comes as the Trump administration intensifies efforts to reshape pharmaceutical pricing abroad through its "Most Favored Nation" (MFN) policy. After striking a deal with the UK, Washington has turned its attention to Germany, launching a Section 301 investigation into whether the country's pharmaceutical pricing policies discriminate against US companies....

Share this article:

Share this:
Related Topics:
Guest Contributor - Opinion

Opinions expressed are purely those of the author and not endorsed by EU Reporter. The article was unsolicited by EU Reporter, and the author guarantees the truthfulness of the contents of the article. No payment was made by EU Reporter to the author

EU Reporter publishes articles from a variety of outside sources which express a wide range of viewpoints. The positions taken in these articles are not necessarily those of EU Reporter. Please see EU Reporter’s full Terms and Conditions of publication for more information EU Reporter embraces artificial intelligence as a tool to enhance journalistic quality, efficiency, and accessibility, while maintaining strict human editorial oversight, ethical standards, and transparency in all AI-assisted content. Please see EU Reporter’s full A.I. Policy for more information.
Advertisement

Trending